name: 3845-Pt_165_normal
characteristics.text: SAMN46033666
characteristics.characteristic: External Id
characteristics.text: dbGaP
characteristics.characteristic: INSDC center name
characteristics.text: 2024-12-30T13:51:47.533Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-04-25T06:06:26.360Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS23731219
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS23731219
characteristics.characteristic: SRA accession
characteristics.text: DNA
characteristics.characteristic: analyte type
characteristics.text: NCI_AtezolizumabBevacizumabTreatment
characteristics.characteristic: biospecimen repository
characteristics.text: Pt_165_normal
characteristics.characteristic: biospecimen repository sample id
characteristics.text: Peripheral Blood
characteristics.characteristic: body site
characteristics.text: phs003845
characteristics.characteristic: gap_accession
characteristics.text: 1
characteristics.characteristic: gap_consent_code
characteristics.text: GRU
characteristics.characteristic: gap_consent_short_name
characteristics.text: 7249279
characteristics.characteristic: gap_sample_id
characteristics.text: 5327747
characteristics.characteristic: gap_subject_id
characteristics.text: No
characteristics.characteristic: is tumor
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: Clinical Trial
characteristics.characteristic: study design
characteristics.text: Anal Cancer
characteristics.characteristic: study disease
characteristics.text: Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
characteristics.characteristic: study name
characteristics.text: Yes
characteristics.characteristic: subject is affected
characteristics.text: Pt_165_normal
characteristics.characteristic: submitted sample id
characteristics.text: Pt_165
characteristics.characteristic: submitted subject id
characteristics.text: NCI_AtezolizumabBevacizumabTreatment
characteristics.characteristic: submitter handle
characteristics.text: Non-tumor DNA sample from Peripheral Blood of a human female participant in the dbGaP study "Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors"
characteristics.characteristic: title